Is a complete IMDX research report available?

No complete published report is available for Insight Molecular Diagnostics Inc. (IMDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Insight Molecular Diagnostics Inc. (IMDX)

NASDAQ: IMDX · USD

$3.11

-0.05 (-1.6%)· Recorded snapshot

Market cap	101.8M
Revenue (ttm)	1.7M
Net income (ttm)	-49.4M
EPS (ttm)	-$1.46
Shares out	32.7M
Volume	79,363
Beta	1.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.7M
Net income (ttm): -49.4M
EPS (ttm): -$1.46
Market cap: 101.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Tut

Metric	Value
Amount currency	USD
CIK code	0001642380
Company name	Insight Molecular Diagnostics Inc.
Country	United States
Country code	US
CUSIP number	68235C206
Earnings date	2026-11-09
Earnings time	amc
Employees	58
Employees change	9
Employees growth	18.37%
Enterprise value	$86.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2009
Industry	Diagnostics & Research
Is primary listing	Yes
Is SPAC	No
ISIN number	US68235C2061
Last 10-K release date	2026-03-26
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2023-07-25
Last stock split type	Reverse
Market cap	$101.8M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$3.11
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	IMDX
U.S. state	Tennessee
Website	https://www.imdxinc.com

Metric

Value

Amount currency

USD

CIK code

0001642380

Company name

Insight Molecular Diagnostics Inc.

Country

United States

Country code

CUSIP number

68235C206

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

Employees growth

18.37%

Enterprise value

$86.6M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2009

Industry

Diagnostics & Research

Is primary listing

Yes

Is SPAC

ISIN number

US68235C2061

Last 10-K release date

2026-03-26

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2023-07-25

Last stock split type

Reverse

Market cap

$101.8M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$3.11

Price currency

USD

Sector

Healthcare

SIC code

2835

Stock price date

2026-10-28

Symbol

IMDX

U.S. state

Tennessee

Website

https://www.imdxinc.com

Metric	Value
Earnings yield	-46.88%
EV/Sales	51.78x
FCF / EV yield	-35.85%
FCF yield	-30.51%
Forward EV/Sales	48.05x
Forward P/S	56.45x
Industry forward P/E	30.87x
Industry P/E	50.24x
P/S ratio	60.84x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-46.88%

EV/Sales

51.78x

FCF / EV yield

-35.85%

FCF yield

-30.51%

Forward EV/Sales

48.05x

Forward P/S

56.45x

Industry forward P/E

30.87x

Industry P/E

50.24x

P/S ratio

60.84x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Gross margin	48.74%
Operating margin	-2,214.73%
Pretax margin	-2,955.63%
Profit per employee	$-851,017
Revenue per employee	$28,793
ROA	-57.82%
ROA (5Y)	-26.54%
ROCE	-193.07%
SBC / revenue	157.72%

Metric

Value

Gross margin

48.74%

Operating margin

-2,214.73%

Pretax margin

-2,955.63%

Profit per employee

$-851,017

Revenue per employee

$28,793

ROA

-57.82%

ROA (5Y)

-26.54%

ROCE

-193.07%

SBC / revenue

157.72%

Metric	Value
EPS growth years	1
Gross profit growth	-65.39%
Gross profit growth (Q)	-53.55%
Gross profit growth 3Y	121.41%
Gross profit growth 5Y	0.17%
Net income growth years	1
Revenue growth	-60.77%
Revenue growth (Q)	-53.86%
Revenue growth (QoQ)	646.88%
Revenue growth 3Y	14.9%
Revenue growth 5Y	-16.89%
Revenue growth years	3

Metric

Value

EPS growth years

Gross profit growth

-65.39%

Gross profit growth (Q)

-53.55%

Gross profit growth 3Y

121.41%

Gross profit growth 5Y

0.17%

Net income growth years

Revenue growth

-60.77%

Revenue growth (Q)

-53.86%

Revenue growth (QoQ)

646.88%

Revenue growth 3Y

14.9%

Revenue growth 5Y

-16.89%

Revenue growth years

Metric	Value
Capital expenditures	$-3.9M
Depreciation and amortization	$2.4M
EBIT	$-37M
EBITDA	$-34.5M
EPS	$-1.46
FCF per share	$-0.95
Financing cash flow	$23.8M
Free cash flow	$-31M
Free cash flow minus SBC	$-33.6M
Gross profit	$814,000
Investing cash flow	$-3.9M
Net borrowing	$-593,000
Net cash flow	$-7.3M
Net income	$-49.4M
Operating cash flow minus SBC	$-29.7M
Operating income	$-37M
Revenue	$1.7M
Stock-based compensation	$2.6M

Metric

Value

Capital expenditures

$-3.9M

Depreciation and amortization

$2.4M

EBIT

$-37M

EBITDA

$-34.5M

EPS

$-1.46

FCF per share

$-0.95

Financing cash flow

$23.8M

Free cash flow

$-31M

Free cash flow minus SBC

$-33.6M

Gross profit

$814,000

Investing cash flow

$-3.9M

Net borrowing

$-593,000

Net cash flow

$-7.3M

Net income

$-49.4M

Operating cash flow minus SBC

$-29.7M

Operating income

$-37M

Revenue

$1.7M

Stock-based compensation

$2.6M

Metric	Value
Altman Z-Score	-21.76
Book value per share	$-0.65
Interest coverage	-377.41
Long-term assets	$8.9M
Long-term liabilities	$40.5M
Net cash (debt)	$15.1M
Net cash / market cap	14.89%
Net cash growth	-27.65%
Piotroski F-Score	1
Property, plant and equipment	$8.1M
Shareholders' equity	$-21.3M
Tangible book value	$-21.3M
Tangible book value per share	$-0.65
Total assets	$29.4M
Total cash	$17.8M
Total debt	$2.6M
Total liabilities	$50.7M
WACC	13.89%

Metric

Value

Altman Z-Score

-21.76

Book value per share

$-0.65

Interest coverage

-377.41

Long-term assets

$8.9M

Long-term liabilities

$40.5M

Net cash (debt)

$15.1M

Net cash / market cap

14.89%

Net cash growth

-27.65%

Piotroski F-Score

Property, plant and equipment

$8.1M

Shareholders' equity

$-21.3M

Tangible book value

$-21.3M

Tangible book value per share

$-0.65

Total assets

$29.4M

Total cash

$17.8M

Total debt

$2.6M

Total liabilities

$50.7M

WACC

13.89%

Metric	Value
Asset turnover	0.04
Current assets	$20.5M
Current liabilities	$10.3M
Current ratio	2
Inventory turnover	1.9
Net working capital	$-5.8M
Quick ratio	1.74
Working capital	$10.3M
Working capital turnover	0.11

Metric

Value

Asset turnover

0.04

Current assets

$20.5M

Current liabilities

$10.3M

Current ratio

Inventory turnover

1.9

Net working capital

$-5.8M

Quick ratio

1.74

Working capital

$10.3M

Working capital turnover

0.11

Metric	Value
Buyback yield / dilution	-52.34%
Dividend yield	0%
Shareholder yield	-52.34%

Metric

Value

Buyback yield / dilution

-52.34%

Dividend yield

Shareholder yield

-52.34%

Metric	Value
10Y price change	-96.23%
10Y return CAGR	-27.94%
10Y total return	-96.23%
150-day SMA	$4.44
1D price change	-1.58%
1M price change	-21.05%
1M total return	-21.05%
1W price change	2.15%
1W total return	2.15%
1Y price change	-52.38%
1Y return CAGR	-52.41%
1Y total return	-52.38%
20-day SMA	$3.15
200-day SMA	$4.77
3M price change	-34.15%
3M total return	-34.15%
3Y price change	35.75%
3Y return CAGR	10.72%
3Y total return	35.75%
50-day SMA	$3.67
50-day SMA vs 200-day SMA	50under200
52-week high	$8.51
52-week high date	2025-11-12
52-week low	$2.42
52-week low date	2026-03-31
5Y price change	-95.21%
5Y return CAGR	-45.54%
5Y total return	-95.21%
6M price change	-19.4%
6M total return	-19.4%
All-time high	$204.80
All-time high date	2016-01-05
All-time low	$1.92
All-time low date	2025-01-22
Average true range (ATR)	$0.31
Average volume	270.5K
Beta (1Y)	2.7
Beta (2Y)	0.88
Beta (5Y)	1.8
Change from 52-week high	-63.45%
Change from 52-week low	28.51%
Change from all-time high	-98.49%
Change from all-time low	61.03%
Change from open	-0.64%
Day's gap	-0.95%
Dollar volume	$246,819
High price	$3.13
Low price	$3.11
Monthly RSI	41.32
Open price	$3.13
Position in 52-week range	0%
Previous close	$3.16
Price vs 150-day SMA	-30.26%
Price vs 20-day SMA	-1.68%
Price vs 200-day SMA	-35.17%
Price vs 50-day SMA	-15.74%
Relative volume	0.29
RSI	44.9
Sharpe ratio	-0.18
Sharpe ratio (3Y)	0.44
Sharpe ratio (5Y)	-0.25
Sortino ratio	-0.21
Sortino ratio (3Y)	0.78
Sortino ratio (5Y)	-0.31
Volume	79.4K
Weekly RSI	35.64
YTD price change	-58.73%
YTD total return	-58.73%

Metric

Value

10Y price change

-96.23%

10Y return CAGR

-27.94%

10Y total return

-96.23%

150-day SMA

$4.44

1D price change

-1.58%

1M price change

-21.05%

1M total return

-21.05%

1W price change

2.15%

1W total return

2.15%

1Y price change

-52.38%

1Y return CAGR

-52.41%

1Y total return

-52.38%

20-day SMA

$3.15

200-day SMA

$4.77

3M price change

-34.15%

3M total return

-34.15%

3Y price change

35.75%

3Y return CAGR

10.72%

3Y total return

35.75%

50-day SMA

$3.67

50-day SMA vs 200-day SMA

50under200

52-week high

$8.51

52-week high date

2025-11-12

52-week low

$2.42

52-week low date

2026-03-31

5Y price change

-95.21%

5Y return CAGR

-45.54%

5Y total return

-95.21%

6M price change

-19.4%

6M total return

-19.4%

All-time high

$204.80

All-time high date

2016-01-05

All-time low

$1.92

All-time low date

2025-01-22

Average true range (ATR)

$0.31

Average volume

270.5K

Beta (1Y)

2.7

Beta (2Y)

0.88

Beta (5Y)

1.8

Change from 52-week high

-63.45%

Change from 52-week low

28.51%

Change from all-time high

-98.49%

Change from all-time low

61.03%

Change from open

-0.64%

Day's gap

-0.95%

Dollar volume

$246,819

High price

$3.13

Low price

$3.11

Monthly RSI

41.32

Open price

$3.13

Position in 52-week range

Previous close

$3.16

Price vs 150-day SMA

-30.26%

Price vs 20-day SMA

-1.68%

Price vs 200-day SMA

-35.17%

Price vs 50-day SMA

-15.74%

Relative volume

0.29

RSI

44.9

Sharpe ratio

-0.18

Sharpe ratio (3Y)

0.44

Sharpe ratio (5Y)

-0.25

Sortino ratio

-0.21

Sortino ratio (3Y)

0.78

Sortino ratio (5Y)

-0.31

Volume

79.4K

Weekly RSI

35.64

YTD price change

-58.73%

YTD total return

-58.73%

Metric	Value
Float	10M
Float percentage	30.49%
Shares change (QoQ)	6.46%
Shares change (YoY)	52.34%
Shares held by insiders	12.29%
Shares held by institutions	10.15%
Shares outstanding	32.7M
Short % of float	9.75%
Short % of shares	2.97%
Short ratio	3.6 days

Metric

Value

Float

10M

Float percentage

30.49%

Shares change (QoQ)

6.46%

Shares change (YoY)

52.34%

Shares held by insiders

12.29%

Shares held by institutions

10.15%

Shares outstanding

32.7M

Short % of float

9.75%

Short % of shares

2.97%

Short ratio

3.6 days

Insight Molecular Diagnostics Inc. (IMDX)

Price

Financial snapshot

Fair-value bridge

Latest news · IMDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IMDX

Frequently asked questions